These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5711443)

  • 21. The coat protein gene of tobacco mosaic virus. I. Location of the gene by mixed infection.
    Kado CI; Knight CA
    J Mol Biol; 1968 Aug; 36(1):15-23. PubMed ID: 5000200
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of coat protein-mediated resistance to TMV. I. The PM2 assembly defective mutant confers resistance to TMV.
    Clark WG; Fitchen JH; Beachy RN
    Virology; 1995 Apr; 208(2):485-91. PubMed ID: 7747421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coat-protein-mediated resistance to tobacco mosaic virus: discovery mechanisms and exploitation.
    Beachy RN
    Philos Trans R Soc Lond B Biol Sci; 1999 Mar; 354(1383):659-64. PubMed ID: 10212946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraction and assay of TMV RNA.
    Fraser RS
    Virology; 1971 Sep; 45(3):804-7. PubMed ID: 5125572
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection against tobacco mosaic virus infection in transgenic plants requires accumulation of coat protein rather than coat protein RNA sequences.
    Powell PA; Sanders PR; Tumer N; Fraley RT; Beachy RN
    Virology; 1990 Mar; 175(1):124-30. PubMed ID: 2309438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopy and infectivity studies of the action of dimethylsulphoxide on two strains of tobacco mosaic virus.
    Nicolaïeff A; Lebeurier G; Hirth L
    J Gen Virol; 1974 Jan; 22(1):43-53. PubMed ID: 4360394
    [No Abstract]   [Full Text] [Related]  

  • 27. The formation of phenotypically mixed particles upon mixed assembly of some tobacco mosaic virus (TMV) strains.
    Taliansky ME; Atabekova TI; Atabekov JG
    Virology; 1977 Feb; 76(2):701-8. PubMed ID: 65827
    [No Abstract]   [Full Text] [Related]  

  • 28. Accumulation of the 126 kDa protein of tobacco mosaic virus during systemic infection analysed by immunocytochemistry and ELISA.
    Wijdeveld MM; Goldbach RW; Meurs C; van Loon LC
    Arch Virol; 1992; 127(1-4):195-207. PubMed ID: 1456890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco mosaic virus coat protein: an elicitor of the hypersensitive reaction but not required for the development of mosaic symptoms in Nicotiana sylvestris.
    Culver JN; Dawson WO
    Virology; 1989 Dec; 173(2):755-8. PubMed ID: 2596036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against tobacco mosaic virus in transgenic plants that express tobacco mosaic virus antisense RNA.
    Powell PA; Stark DM; Sanders PR; Beachy RN
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6949-52. PubMed ID: 2476807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogold localization of the intracellular sites of structural and nonstructural tobacco mosaic virus proteins.
    Hills GJ; Plaskitt KA; Young ND; Dunigan DD; Watts JW; Wilson TM; Zaitlin M
    Virology; 1987 Dec; 161(2):488-96. PubMed ID: 3318095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are the PR1 proteins of tobacco involved in genetically engineered resistance to TMV?
    Carr JP; Beachy RN; Klessig DF
    Virology; 1989 Apr; 169(2):470-3. PubMed ID: 2705308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of alfalfa mosaic virus coat protein in tobacco mosaic virus (TMV) deficient in the production of its native coat protein supports long-distance movement of a chimeric TMV.
    Spitsin S; Steplewski K; Fleysh N; Belanger H; Mikheeva T; Shivprasad S; Dawson W; Koprowski H; Yusibov V
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2549-53. PubMed ID: 10051680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased levels of TMV coat protein in transgenic tobacco plants at elevated temperatures reduce resistance to TMV infection.
    Nejidat A; Beachy RN
    Virology; 1989 Dec; 173(2):531-8. PubMed ID: 2596028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cycloheximide on tobacco mosaic virus synthesis in callus from hypersensitive tobacco.
    Beachy RN; Murakishi HH
    Virology; 1973 Oct; 55(2):320-8. PubMed ID: 4742776
    [No Abstract]   [Full Text] [Related]  

  • 36. Specificity of TMV RNA encapsidation: in vitro coating of heterologous RNA by TMV protein.
    Fritsch C; Stussi C; Witz J; Hirth L
    Virology; 1973 Nov; 56(1):33-45. PubMed ID: 4355530
    [No Abstract]   [Full Text] [Related]  

  • 37. Replication of tobacco mosaic virus. IV. Further characterization of viral related RNAs.
    Siegel A; Zaitlin M; Duda CT
    Virology; 1973 May; 53(1):75-83. PubMed ID: 4706712
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction by 2-chloroethylophosphonic acid of viral-like lesions, associated proteins, and systemic resistance in tobacco.
    van Loon LC
    Virology; 1977 Jul; 80(2):417-20. PubMed ID: 888353
    [No Abstract]   [Full Text] [Related]  

  • 39. Complementation of coat protein-defective TMV mutants in transgenic tobacco plants expressing TMV coat protein.
    Osbourn JK; Sarkar S; Wilson TM
    Virology; 1990 Dec; 179(2):921-5. PubMed ID: 2238482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple serine phosphorylation sites on the 30 kDa TMV cell-to-cell movement protein synthesized in tobacco protoplasts.
    Haley A; Hunter T; Kiberstis P; Zimmern D
    Plant J; 1995 Nov; 8(5):715-24. PubMed ID: 8528282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.